Spring cleaning: time to rethink imaging research lines in MS?

Martina Absinta, Daniel S. Reich, Massimo Filippi

Research output: Contribution to journalArticle

Abstract

Together with recently advanced MRI technological capability, new needs and updated questions are emerging in imaging research in multiple sclerosis (MS), especially with respect to the identification of novel in vivo biomarkers of MS-relevant pathological processes. Expected benefits will involve approaches to diagnosis and clinical classification. In detail, three main points of discussion are addressed in this review: (1) new imaging biomarkers (centrifugal/centripetal lesion enhancement, central vein, paramagnetic rims at the lesion edge, subpial cortical demyelination); (2) thinking about high-resolution MR from a pathological perspective (from postmortem to in vivo staging); and (3) the clinical utility of quantitative MRI. In this context, research efforts should increasingly be focused on the direct in vivo visualization of “hidden” inflammation, beyond what can be detected with conventional gadolinium-based methods, as well as remyelination and repair, since these are likely to represent critical pathological processes and potential therapeutic targets. Concluding remarks concern the limitations, challenges, and ultimately clinical role of non-conventional MRI techniques.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalJournal of Neurology
DOIs
StateAccepted/In press - Feb 17 2016
Externally publishedYes

Fingerprint

Pathologic Processes
Multiple Sclerosis
Biomarkers
Gadolinium
Demyelinating Diseases
Research
Veins
Inflammation
Therapeutics

Keywords

  • Biomarkers
  • Multiple sclerosis
  • Neuroimaging

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Spring cleaning : time to rethink imaging research lines in MS? / Absinta, Martina; Reich, Daniel S.; Filippi, Massimo.

In: Journal of Neurology, 17.02.2016, p. 1-10.

Research output: Contribution to journalArticle

Absinta, Martina ; Reich, Daniel S. ; Filippi, Massimo. / Spring cleaning : time to rethink imaging research lines in MS?. In: Journal of Neurology. 2016 ; pp. 1-10.
@article{bdde25fd20934cefb71faf2defc8d1c4,
title = "Spring cleaning: time to rethink imaging research lines in MS?",
abstract = "Together with recently advanced MRI technological capability, new needs and updated questions are emerging in imaging research in multiple sclerosis (MS), especially with respect to the identification of novel in vivo biomarkers of MS-relevant pathological processes. Expected benefits will involve approaches to diagnosis and clinical classification. In detail, three main points of discussion are addressed in this review: (1) new imaging biomarkers (centrifugal/centripetal lesion enhancement, central vein, paramagnetic rims at the lesion edge, subpial cortical demyelination); (2) thinking about high-resolution MR from a pathological perspective (from postmortem to in vivo staging); and (3) the clinical utility of quantitative MRI. In this context, research efforts should increasingly be focused on the direct in vivo visualization of “hidden” inflammation, beyond what can be detected with conventional gadolinium-based methods, as well as remyelination and repair, since these are likely to represent critical pathological processes and potential therapeutic targets. Concluding remarks concern the limitations, challenges, and ultimately clinical role of non-conventional MRI techniques.",
keywords = "Biomarkers, Multiple sclerosis, Neuroimaging",
author = "Martina Absinta and Reich, {Daniel S.} and Massimo Filippi",
year = "2016",
month = "2",
day = "17",
doi = "10.1007/s00415-016-8060-0",
language = "English (US)",
pages = "1--10",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "D. Steinkopff-Verlag",

}

TY - JOUR

T1 - Spring cleaning

T2 - time to rethink imaging research lines in MS?

AU - Absinta, Martina

AU - Reich, Daniel S.

AU - Filippi, Massimo

PY - 2016/2/17

Y1 - 2016/2/17

N2 - Together with recently advanced MRI technological capability, new needs and updated questions are emerging in imaging research in multiple sclerosis (MS), especially with respect to the identification of novel in vivo biomarkers of MS-relevant pathological processes. Expected benefits will involve approaches to diagnosis and clinical classification. In detail, three main points of discussion are addressed in this review: (1) new imaging biomarkers (centrifugal/centripetal lesion enhancement, central vein, paramagnetic rims at the lesion edge, subpial cortical demyelination); (2) thinking about high-resolution MR from a pathological perspective (from postmortem to in vivo staging); and (3) the clinical utility of quantitative MRI. In this context, research efforts should increasingly be focused on the direct in vivo visualization of “hidden” inflammation, beyond what can be detected with conventional gadolinium-based methods, as well as remyelination and repair, since these are likely to represent critical pathological processes and potential therapeutic targets. Concluding remarks concern the limitations, challenges, and ultimately clinical role of non-conventional MRI techniques.

AB - Together with recently advanced MRI technological capability, new needs and updated questions are emerging in imaging research in multiple sclerosis (MS), especially with respect to the identification of novel in vivo biomarkers of MS-relevant pathological processes. Expected benefits will involve approaches to diagnosis and clinical classification. In detail, three main points of discussion are addressed in this review: (1) new imaging biomarkers (centrifugal/centripetal lesion enhancement, central vein, paramagnetic rims at the lesion edge, subpial cortical demyelination); (2) thinking about high-resolution MR from a pathological perspective (from postmortem to in vivo staging); and (3) the clinical utility of quantitative MRI. In this context, research efforts should increasingly be focused on the direct in vivo visualization of “hidden” inflammation, beyond what can be detected with conventional gadolinium-based methods, as well as remyelination and repair, since these are likely to represent critical pathological processes and potential therapeutic targets. Concluding remarks concern the limitations, challenges, and ultimately clinical role of non-conventional MRI techniques.

KW - Biomarkers

KW - Multiple sclerosis

KW - Neuroimaging

UR - http://www.scopus.com/inward/record.url?scp=84958756411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958756411&partnerID=8YFLogxK

U2 - 10.1007/s00415-016-8060-0

DO - 10.1007/s00415-016-8060-0

M3 - Article

C2 - 26886204

AN - SCOPUS:84958756411

SP - 1

EP - 10

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

ER -